StockData
Bright Minds Biosciences Inc. logo

Bright Minds Biosciences Inc. (DRUG) stock

DRUGNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 40-F on Dec 23, 2025Score 5/30
$20.76+0.25 (+1.22%)

Close on Nov 18, 2026Market cap $158.52MP/E –Yield –

Bright Minds Biosciences cash

Cash and short-term investments held at the end of each period.

Bright Minds Biosciences's cash was C$82.91M at Sep 30, 2025. For fiscal 2025 it was C$82.91M, up 1349.4% from the year before. The highest annual figure on record is C$82.91M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Sep 30, 2025C$82.91M+1349.4%
FY2024Sep 30, 2024C$5.72M-15.2%
FY2023Sep 30, 2023C$6.75M-42.0%
FY2022Sep 30, 2022C$11.63M-41.2%
FY2021Sep 30, 2021C$19.76M+2370.2%
FY2020Sep 30, 2020C$799.93K+900.0%
FY2019Sep 30, 2019C$79.99K–
FY2018Sep 30, 2018C$0–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2025CQ3 2025Sep 30, 2025C$82.91M+319.6%
Q4 FY2024CQ3 2024Sep 30, 2024C$5.72M+615.1%
Q4 FY2023CQ3 2023Sep 30, 2023C$6.75M+8335.9%
Q4 FY2022CQ3 2022Sep 30, 2022C$11.63M–
Q4 FY2021CQ3 2021Sep 30, 2021C$19.76M–
Q4 FY2020CQ3 2020Sep 30, 2020C$799.93K–
Q4 FY2019CQ3 2019Sep 30, 2019C$79.99K–
Q4 FY2018CQ3 2018Sep 30, 2018C$0–

More Bright Minds Biosciences figures

See a number that looks wrong?